Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673721 · ClinicalTrials.gov registry record · NA
PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT04673721 is a NA study that has completed, run by Duke University. The registered enrollment target is 140 participants.
The verdict
NCT04673721, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The objective of the study is to assess the effect of fortified eggs (compared to a non-egg supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial comparing fortified eggs vs. a non-egg supplemented diet and IF vs. usual care diet through 4 months. Participants will be randomized 1:1:1:1 to the four treatment groups. Participants will have in-person follow-up visits at 1- and 4- months (inclusive of laboratory assessments) in addition to telephone calls at months 2 and 3. A subset of patients (\~24 in each egg randomized strata) will undergo microbiome assessment at baseline and at 4 months.
Interventions
- DIETARY_SUPPLEMENT Fortified eggs
- BEHAVIORAL Intermittent fasting
- DIETARY_SUPPLEMENT Non-egg supplemented
- BEHAVIORAL Usual care diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-01-06 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04673721
The ClinicalTrials.gov registry entry for NCT04673721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fortified eggs is the first listed.
NCT04673721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04673721 about?
NCT04673721 is a clinical study titled "PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health". The objective of the study is to assess the effect of fortified eggs (compared to a non-egg supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial comparing fortified ...
What is the current status of trial NCT04673721?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2021-01-06. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT04673721?
The interventions under investigation include: Fortified eggs (DIETARY_SUPPLEMENT), Intermittent fasting (BEHAVIORAL), Non-egg supplemented (DIETARY_SUPPLEMENT), Usual care diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673721?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.